Maharashtra FDA Urges Price Control on Essential Medical Devices

Maharashtra's Food and Drug Administration found large price gaps between procurement costs and maximum retail prices of hospital medical devices. The FDA has asked the central government to investigate these discrepancies and implement price controls on essential devices used in inpatient care. This move aims to increase transparency and reduce patient healthcare expenses by addressing regulatory gaps.

Tip: use ↑ / ↓ (or j / k) to move between stories.